COMP <GO>
NVST vs LLY // FREE CASH FLOW YIELD
Envista Holdings Corporation (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: NVST 4
— LLY 10
▲ FREE CASH FLOW YIELD LEADER: NVST
LAST: $23.51 (-4.47%) • MKT CAP: $3.95B
fcf-yield
5.83%
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
fcf-yield
2.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NVST VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NVST | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.70% | 83.64% | -28.94 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.10% | 32.36% | -27.26 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.5x | 36.4x | -19.92 | NVST | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 5.83% | 2.30% | +3.53 | NVST | /fcf-yield <GO> |
| Operating Margin | 7.90% | 40.21% | -32.31 | LLY | /operating-margins <GO> |
| Net Profit Margin | 1.70% | 31.90% | -30.20 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 8.30% | 45.51% | -37.21 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.61 | 9.29 | -7.68 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.77% | -0.07 | NVST | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.7 | 77.9 | -30.22 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.51 | +0.42 | NVST | /macro-sensitivity <GO> |
| Forward P/E Multiple | 78.2x | 26.3x | +51.95 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.95B | $1.33T | -$1.33T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NVST REV | LLY REV | NVST GROSS % | LLY GROSS % | NVST FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.72B | $65.18B | 54.7% | 83.0% | $230.4M | $16.81B |
| FY 2024 | $2.51B | $45.04B | 54.7% | 81.3% | $302.7M | $8.82B |
| FY 2023 | $2.57B | $34.12B | 44.0% | 79.3% | $160.2M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NVST // BETA 0.93
LLY // BETA 0.51